The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2019 | ASH CAR-T and gene editing highlights
John DiPersio
• 7 Dec 2019
John DiPersio, MD, PhD, Washington University School of Medicine, Saint Louis, MO, highlights the key updates in CAR T-cell therapy from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Dr DiPersio specifically discusses new CAR-T therapies, and the combination of CAR-T therapy with gene editing platforms.
